BioSymetrics CSO Gabe Musso to Present on Artificial Intelligence and Machine Learning for Biomedical R&D Innovation at the 2019 BIO International Convention
PHILADELPHIA – (June 3, 2019) – Biomedical artificial intelligence (AI) company BioSymetrics will offer a presentation on the use of AI and machine learning for healthcare and biomedical R&D innovation at the 2019 BIO International Convention, which is being held June 3-6 at the Pennsylvania Convention Center in Philadelphia. The company’s Chief Scientific Office, Gabe Musso, will lead the presentation on Wednesday, June 5, at 11:15 am, in Theater 3.
BioSymetrics is pioneering proprietary data science and machine learning software in order to best optimize medical discovery and life sciences productivity. Musso, who will be available for meetings at BIO, can discuss how BioSymetrics has developed diagnostic models for Autism Spectrum Disorder, Alzheimer’s disease and cardiac arrhythmias, and how its inaugural product, the AugustaÔ software platform, provides a holistic solution to some of the current industry challenges, including the utilization of good data without bias to feed machine learning models. BioSymetrics simplifies biomedical data science projects by reducing the time spent on data pre-processing, thus ultimately helping to build more effective predictive models that enable solutions to reach the market more quickly.
Media & Analyst Briefings
To schedule a briefing with BioSymetrics at BIO, please contact BioSymetrics’ PR team at 774-551-6679 or email@example.com.
For additional information, visit http://biosymetrics.com.
Korie Grill, Account Executive